Aurobindo Pharma informs about unaudited financial results

10 Feb 2023 Evaluate

Pursuant to Regulation 33(3) (d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Aurobindo Pharma has submitted the Unaudited Financial Results for the Quarter and Nine Months ended on 31st December, 2022 along with Limited Review Report.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1193.70 21.20 (1.81%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×